Eyegene

Developer of immune vaccines and diagnostic systems for eye disorders

placeSeoul, Seoul, South Korea calendar_todayFounded 2000 groups89 employees language eyegene.co.kr

Investor mix

8 investors on record.

Investor typeCountShare
Venture capital675%
Private equity113%
Bank & private debt113%
Coming soon